EPS for Innovus Pharmaceuticals, Inc. (INNV) Expected At $-0.01 on April, 1

Investors expect Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV)’s quarterly earnings on April, 1., as reported by RTT. Analysts predict $-0.01 earnings per share, which is $0.00 or 0.00 % from 2018’s $-0.01 earnings per share. Wall Street now predicts 0.00 % EPS growth despite Innovus Pharmaceuticals, Inc. last quarter’s EPS of $-0.01. Ticker’s shares touched $0.0474 during the last trading session after 3.04% change.Currently Innovus Pharmaceuticals, Inc. is after 0.00% change in last March 15, 2018. INNV has 4,000 shares volume. The stock underperformed the S&P500 by 4.37%.

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States.The firm is worth $11.61 million. The Company’s products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality.Currently it has negative earnings. The firm also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence.

For more Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) news announced recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “MedMen Vs. Acreage: The Battle For American Cannabis Leadership – acrgf – Seeking Alpha” announced on December 14, 2018, “Innovus Pharma expands into CBD oil-based products market – Seeking Alpha” on October 18, 2018, “Innovus Pharmaceuticals (INNV) Investor Presentation – Slideshow – Seeking Alpha” with a publish date: June 19, 2017, “Innovus Pharma’s UriVarx shows positive effect in overactive bladder study – Seeking Alpha” and the last “Innovus Pharma merges with Novalere FP, nabs rights to steroid nasal spray – Seeking Alpha” with publication date: February 05, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.